Clinical TrialsSearch results
Number of results: 298
Other
- Assessment of Beta-Blocker Treatment in Japanese Patients with Chronic Heart Failure
- Chronic heart failure
- J-CHF Study Group
- 2006-12-13
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- NPB-01(intravenous immunoglobulin)therapy for patients with pemphigus unresponsive to corticosteroids:Multi-center,Randomized,Double-Blind ,Placebo Control,Parallel Assignment Study to examine dose response and efficacy of NPB-01.(Phase2+3)
- Pemphigus
- NIHON PHARMACEUTICAL CO.,LTD
- 2006-12-01
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28
Other
- A randomized phase III trial of AP(Doxorubicin+Cisplatin) versus DP(Docetaxel+Cisplatin), TC(Paclitaxel+Carboplatin) as adjuvant chemotherrapy in patients with high risk group of endometrial carcinoma
- patients with high risk group of endometrial carcinoma which is removed surgically
- Japanese Gynecologic Oncology Group
- 2006-11-15
Other
- Japanese Research of Cholesterol and Diabetes Mellitus
- Diabetics and the patients with impaired glucose tolerance
- AMED
- 2006-11-10
Other
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05: A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Myeloid Leukemia
- Acute Myeloid Leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2006-11-01
Other
- Lung Cancer Evaluation of TS-1 Study
- Previously untreated stageIIIB/IV NSCLC
- West Japan Oncology Group
- 2006-10-18
Other
- Study of High dose Toremifene for metastatic breast cancer after failure of adjuvant therapy of Aromatase Inhibitor
- First line therapy for recurrence or metastatic postmenopausal breast cancer
- Nagoya University of School of Medicine Breast and Endocrine Surgery
- 2006-10-01
Other
- Concurrent Treatment of Cardiovascular Disease in Peritoneal Dialysis (PD) patients. Multi-center Randomized Clinical Study with Aldosterone blockade (spironolactone) and Angiotensin Receptor Blocker (ARB) or Angiotensin-Converting-Enzyme Inhibitor (ACEI).
- End-Stage Renal Disease (ESRD) and Cardio-Vascular Disease (CVD)
- Nagoya University
- 2006-10-01